Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia Jun 4, 2019
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference May 21, 2019
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel May 15, 2019
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia Apr 15, 2019
Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal Apr 1, 2019
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd Mar 26, 2019
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th Mar 13, 2019
